Modulation of Amyloid Beta Protein Precursor Processing As a Means of Retarding Progression of Alzheimer's Disease

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1999 Nov 24

PMID 10562291

Citations 4

Authors

S L Wagner

B Munoz

Affiliations

Soon will be listed here.

Citing Articles

Sensitive and continuous screening of inhibitors of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) at single SPR chips.

Yi X, Hao Y, Xia N, Wang J, Quintero M, Li D Anal Chem. 2013; 85(7):3660-6.

PMID: 23432118 PMC: 3635668. DOI: 10.1021/ac303624z.

Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.

Kounnas M, Danks A, Cheng S, Tyree C, Ackerman E, Zhang X Neuron. 2010; 67(5):769-80.

PMID: 20826309 PMC: 2947312. DOI: 10.1016/j.neuron.2010.08.018.

Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer's disease in Chinese.

Kan R, Wang B, Zhang C, Jin F, Yang Z, Ji S J Mol Neurosci. 2005; 25(2):127-31.

PMID: 15784960 DOI: 10.1385/JMN:25:2:127.

Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase.

Balasubramanian A Neurochem Res. 2001; 26(4):453-6.

PMID: 11495357 DOI: 10.1023/a:1010967602362.

References

Goate A, Chartier-Harlin M, Mullan M, Brown J, Crawford F, Fidani L . Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349(6311):704-6. DOI: 10.1038/349704a0. View

Lamb B, Bardel K, Kulnane L, Anderson J, Holtz G, Wagner S . Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci. 1999; 2(8):695-7. DOI: 10.1038/11154. View

Rogers J, Cooper N, Webster S, Schultz J, McGeer P, Styren S . Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992; 89(21):10016-20. PMC: 50268. DOI: 10.1073/pnas.89.21.10016. View

Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L . Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992; 258(5079):126-9. DOI: 10.1126/science.1439760. View

Cai X, Golde T, Younkin S . Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 1993; 259(5094):514-6. DOI: 10.1126/science.8424174. View

Hardy J . Framing beta-amyloid. Nat Genet. 1992; 1(4):233-4. DOI: 10.1038/ng0792-233. View

JARRETT J, Lansbury Jr P . Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell. 1993; 73(6):1055-8. DOI: 10.1016/0092-8674(93)90635-4. View

Loo D, Copani A, Pike C, Whittemore E, Walencewicz A, Cotman C . Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A. 1993; 90(17):7951-5. PMC: 47265. DOI: 10.1073/pnas.90.17.7951. View

Hensley K, Carney J, Mattson M, Aksenova M, Harris M, Wu J . A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A. 1994; 91(8):3270-4. PMC: 43558. DOI: 10.1073/pnas.91.8.3270. View

10.

Behl C, Davis J, Lesley R, Schubert D . Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994; 77(6):817-27. DOI: 10.1016/0092-8674(94)90131-7. View

11.

Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y . Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994; 13(1):45-53. DOI: 10.1016/0896-6273(94)90458-8. View

12.

Sherrington R, Rogaev E, Liang Y, Rogaeva E, Levesque G, Ikeda M . Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995; 375(6534):754-60. DOI: 10.1038/375754a0. View

13.

Levy-Lahad E, Wasco W, Poorkaj P, Romano D, Oshima J, Pettingell W . Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995; 269(5226):973-7. DOI: 10.1126/science.7638622. View

14.

Kingston I, Castro M, Anderson S . In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat Med. 1995; 1(2):138-42. DOI: 10.1038/nm0295-138. View

15.

Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N . Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996; 2(8):864-70. DOI: 10.1038/nm0896-864. View

16.

Boggs L, Fuson K, Baez M, Churgay L, McClure D, Becker G . Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity. J Neurochem. 1996; 67(3):1324-7. DOI: 10.1046/j.1471-4159.1996.67031324.x. View

17.

Chen S, Frederickson R, Brunden K . Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol Aging. 1996; 17(5):781-7. DOI: 10.1016/0197-4580(96)00103-0. View

18.

Esler W, Stimson E, Ghilardi J, Felix A, Lu Y, Vinters H . A beta deposition inhibitor screen using synthetic amyloid. Nat Biotechnol. 1997; 15(3):258-63. DOI: 10.1038/nbt0397-258. View

19.

Solomon B, Koppel R, Frankel D . Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci U S A. 1997; 94(8):4109-12. PMC: 20576. DOI: 10.1073/pnas.94.8.4109. View

20.

Tjernberg L, Lilliehook C, Callaway D, Naslund J, Hahne S, Thyberg J . Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem. 1997; 272(19):12601-5. DOI: 10.1074/jbc.272.19.12601. View